Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer

被引：2
|
作者：
Alba, Emilio
Rueda, Oscar M.
Lluch, Ana
Albanell, Joan
Chin, Suet-Feung
Chacon, Jose Ignacio
Calvo, Lourdes
De La Haba, Juan
Bermejo, Begona
Ribelles, Nuria
Cirauqui, Beatriz
Ramos Vazquez, Manuel
Arcusa Lanza, Maria Angeles
Maria Carrasco, Eva
Herranz, Jesus
Chiesa, Massimo
Caballero, Rosalia
Santonja Climent, Angela
Rojo, Federico
Caldas, Carlos
机构：
[1] Hosp Clin Univ Virgen de la Victoria, GEICAM Spanish Breast Canc Grp, Malaga, Spain
[2] Canc Res UK Cambridge Inst, Cambridge, England
[3] Hosp Clin Univ Valencia, GEICAM Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII, Valencia, Spain
[4] Hosp del Mar, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[5] Canc Res UK, Cambridge Res Inst, Cambridge, England
[6] Hosp Virgen de la Salud, GEICAM Spanish Breast Canc Grp, Toledo, Spain
[7] Complejo Hosp Univ A Coruna, GEICAM Spanish Breast Canc Grp, La Coruna, Spain
[8] Univ Cordoba, Biomed Res Inst Maimonides, Hosp Univ Reina Sofia, Cordoba, Spain
[9] Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII GEICAM, Cordoba, Spain
[10] Hosp Univ Reg & Virgen de la Victoria Malaga, IBIMA, Unidad Gest Clin Interctr Oncol, Malaga, Spain
[11] Hosp Badalona Germans Trias & Pujol, Med Oncol Dept, Catalan Inst Oncol, Badalona, Spain
[12] GEICAM Spanish Breast Canc Grp, Ctr Oncol Galicia, La Coruna, Spain
[13] Hosp Terrassa, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[14] GEICAM Spanish Breast Canc Grp, Madrid, Spain
[15] Hosp Clin Univ Virgen de la Victoria, Malaga, Spain
[16] Fdn Jimenez Diaz, Madrid, Spain
[17] CIBERONC ISCIII, Ctr Invest Biomed Red Oncol, Madrid, Spain
[18] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
579
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [22] Pathological complete response (pCR) after neoadjuvant chemotherapy in luminal breast cancer
    Cordoba Ortega, J. F.
    Gasol Cudos, A.
    Morales Murillo, S.
    Vilardell Villellas, F.
    Siso Raber, C.
    Canosa Morales, C.
    Salud Salvia, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S313 - S313
  • [23] Magnetic Resonance Imaging to predict pathological response neoadjuvant chemotherapy for breast cancer
    Lamot, C.
    Van fraeyenhove, F.
    Denys, H.
    Van Herreweghe, E.
    Van den Broecke, R.
    Villeirs, G.
    Depypere, H.
    Praet, M.
    Cocquyt, V.
    EJC SUPPLEMENTS, 2008, 6 (07): : 60 - 61
  • [24] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [25] Can mammographic breast density predict complete pathological response in patients with locally advanced breast cancer following neoadjuvant chemotherapy?
    Agarwal, Veenoo
    Spalding, Lisa
    Blick, Tony
    Thompson, Erik W.
    Dobrovic, Alexander
    Redfern, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 65 - 65
  • [26] MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
    Briete Goorts
    Kelly M. A. Dreuning
    Janneke B. Houwers
    Loes F. S. Kooreman
    Evert-Jan G. Boerma
    Ritse M. Mann
    Marc B. I. Lobbes
    Marjolein L. Smidt
    Breast Cancer Research, 20
  • [27] MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
    Goorts, Briete X. Z.
    Dreuning, Kelly M. A.
    Houwers, Janneke B.
    Kooreman, Loes F. S.
    Boerma, Evert-Jan G.
    Mann, Ritse M.
    Lobbes, Marc B. I.
    Smidt, Marjolein L.
    BREAST CANCER RESEARCH, 2018, 20
  • [28] Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
    Ring, AE
    Smith, IE
    Ashley, S
    Fulford, LG
    Lakhani, SR
    BRITISH JOURNAL OF CANCER, 2004, 91 (12) : 2012 - 2017
  • [29] Early-onset Brain Metastases in a Breast Cancer Patient after Pathological Complete Response to Neoadjuvant Chemotherapy
    Shimada, Kazuhiro
    Ishikawa, Takashi
    Yoneyama, Shuko
    Kita, Kumiko
    Narui, Kazutaka
    Sugae, Sadayoshi
    Shimizu, Daisuke
    Tanabe, Mikiko
    Sasaki, Takeshi
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    ANTICANCER RESEARCH, 2013, 33 (11) : 5119 - 5121
  • [30] Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
    A E Ring
    I E Smith
    S Ashley
    L G Fulford
    S R Lakhani
    British Journal of Cancer, 2004, 91 : 2012 - 2017
12345